ArticleAsian Pacific journal of cancer prevention : APJCP2025

The p16 Immunostaining Predicts the Risk of Recurrence in Prostate Cancer.

Sara Lourrane Carneiro De Andrade Cavalcante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.